Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821105 · ClinicalTrials.gov registry record · Phase 2
2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer
A Phase 2 study of Recurrent Colon Cancer and Recurrent Rectal Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01821105: Completed Phase 2 study of Recurrent Colon Cancer and Recurrent Rectal Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01821105 is a Phase 2 study of Recurrent Colon Cancer and Recurrent Rectal Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 21 participants, below the 29-participant average among 10 other Recurrent Colon Cancer trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01821105, a Phase 2 study of Recurrent Colon Cancer and Recurrent Rectal Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot phase II studies how well computed tomography (CT) and positron emission tomography (PET) imaging works in detecting disease in patients undergoing surgery for metastatic colorectal cancer. Diagnostic procedures, such as CT and PET scans, done before and during surgery may help find colorectal cancer and help guide surgery
Conditions Studied
Interventions
- PROCEDURE CT Scan
- RADIATION fludeoxyglucose F 18
- PROCEDURE PET Scan
- PROCEDURE computer-aided detection/diagnosis
Study Locations (1)
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2004-03 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
What the finished NCT01821105 record still lists
NCT01821105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 29-participant average among 10 other Recurrent Colon Cancer trials with a reported enrollment target (28% lower).
The record links to 6 conditions, with Recurrent Colon Cancer appearing as the primary indexed condition, and to 4 interventions - of which CT Scan is the first listed.
NCT01821105 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01821105 about?
NCT01821105 is a clinical study titled "2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer". This pilot phase II studies how well computed tomography (CT) and positron emission tomography (PET) imaging works in detecting disease in patients undergoing surgery for metastatic colorectal cancer. Diagnostic procedures, such as CT and PET scans, done before and during surgery may help find color...
What is the current status of trial NCT01821105?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2004-03. Estimated completion is 2009-11.
What conditions does trial NCT01821105 study?
This clinical trial studies the following conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer.
What interventions are being tested in trial NCT01821105?
The interventions under investigation include: CT Scan (PROCEDURE), fludeoxyglucose F 18 (RADIATION), PET Scan (PROCEDURE), computer-aided detection/diagnosis (PROCEDURE).
Who is sponsoring clinical trial NCT01821105?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01821105 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01821105's enrollment target sits among peer trials
21 5th of 10 higher than 6 of 10 other Recurrent Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Recurrent Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
COMPLETED · Phase 2
-
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
COMPLETED · Phase 2
-
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
COMPLETED · Phase 2
-
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
COMPLETED · Phase 1
-
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
COMPLETED · Phase 1
-
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia